Free 7-day Trial
All Articles and Columns »

Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 5,000 Shares

December 14, 2012 | About:
insider

insider

52 followers
CEO of Biomarin Pharmaceutical, Inc. (BMRN) Jean Jacques Bienaime sells 5,000 shares of BMRN on 12/12/2012 at an average price of $50 a share.

Biomarin Pharmaceutical, Inc. has a market cap of $5.99 billion; its shares were traded at around $49.31 with and P/S ratio of 12.

This is the annual revenues and earnings per share of BMRN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of BMRN.


CEO Recent Trades:



  • CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 12/12/2012 at the average price of 50. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has decreased by 1.38% since.
  • CEO Jean Jacques Bienaime sold 6,000 shares of BMRN stock on 12/10/2012 at the average price of 47.53. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 3.75% since.
  • CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 12/04/2012 at the average price of 47.94. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 2.86% since.
  • CEO Jean Jacques Bienaime sold 8,000 shares of BMRN stock on 11/16/2012 at the average price of 48.05. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 2.62% since.
  • CEO Jean Jacques Bienaime sold 4,000 shares of BMRN stock on 11/14/2012 at the average price of 48.5. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 1.67% since.

This is the insider trade history vs. stock price of BMRN. For the complete insider trading history of BMRN, click here.




Directors and Officers Recent Trades:



  • Director Richard A Meier sold 5,000 shares of BMRN stock on 12/11/2012 at the average price of 49.71. Richard A Meier owns at least 18,650 shares after this. The price of the stock has decreased by 0.8% since.
  • Director Richard A Meier sold 5,000 shares of BMRN stock on 11/29/2012 at the average price of 49.17. Richard A Meier owns at least 18,650 shares after this. The price of the stock has increased by 0.28% since.
  • SVP, Chief Commercial Of Jeffrey Robert Ajer sold 5,916 shares of BMRN stock on 11/28/2012 at the average price of 48.31. Jeffrey Robert Ajer owns at least 10,570 shares after this. The price of the stock has increased by 2.07% since.
  • VP, Human Resources Mark Wood sold 2,665 shares of BMRN stock on 11/23/2012 at the average price of 48.92. Mark Wood owns at least 32,364 shares after this. The price of the stock has increased by 0.8% since.
  • SVP, General Counsel George Eric Davis sold 7,363 shares of BMRN stock on 11/19/2012 at the average price of 48.5. George Eric Davis owns at least 51,322 shares after this. The price of the stock has increased by 1.67% since.


For the complete insider trading history of BMRN, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 2.7/5 (3 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide